About

About
The DS management team has both a strong background in developing drugs for the market and experience in building life science companies.

Pipeline

Pipeline
DS Biopharma have three novel assets in various stages of clinical and pre-clinical development and intend to add more bioactive lipids to the current portfolio in the coming years.

Investors

Investors
To date, DS Biopharma have been funded privately.

Latest News

November 28, 2016

DS Biopharma to present at Piper Jaffray 28th Annual Healthcare Conference

Dublin, Ireland, 28th November, 2016: DS Biopharma (DS), a privately held drug discovery and development company, today announced that it will present an overview of the […]
September 29, 2016

DS Biopharma will today present data on a Phase IIa study at the European Academy of Dermatology and Venereology (EADV) Congress

Dublin, Ireland, 29th September 2016: DS Biopharma (DS) will today present data on their Phase IIa study with DS107 for the treatment of atopic dermatitis at […]

Join our mailing list

Connect with us